Manuscripts must be written in English. Review Articles, full-length Original Articles, Case Reports, and articles describing new or improved relevant methods are accepted.
All manuscripts submitted to MEBM have to positively pass the peer-review process. If the Editor decides that the manuscript fits to the aims and scope of the journal, the Editor will identify and contact two independent reviewers who are acknowledged experts in the field.
For MEBM, the average editorial time from submission to first decision is 8 weeks.
In case that the Editor decides that your manuscript does not meet the journal aims and scope, the Editor will notify you that the manuscript has been rejected and may recommend a more suitable journal.
Manuscript must be accompanied by a cover letter signed by all authors that should contain following:
- full title of the manuscript
- name, affiliation, postal address, postal code, and e-mail address of the corresponding author
- a statement about any financial or other conflict of interest, must be in separate document file, not within the manuscript
- in case that authors would like to suggest reviewers (maximum two authors with their full names, Institutions and e-mail addresses) it is possibly to do at the end of the cover letter
Review articles (maximum 10 printed pages) on recent developments in areas covered by the journal are invited. Review articles should not include results, which have not been previously published. Invited review articles will get priority over uninvited submissions.
Limit - 4500 words excluding references, tables, and figures)
Abstract - 200 words maximum
References - up to 70
Review articles should include the following sections: Title Page (including the given name/s and family name/s of each author, the authors' affiliation addresses - indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address, indicate the corresponding author’s e-mail address), Abstract (number of words specified above), Keywords (4-8), Introduction, Discussion, Conclusions, Acknowledgements (if applicable), References, Tables (if applicable), and Figures (if applicable).
Full-length Original Articles
Full-length original articles of original, basic or clinical research, with new data, investigated using the scientific methods, may be submitted as a research paper.
Limit - 3500 words (excluding references, tables, and figures)
Abstract - 200 words maximum
References - up to 50
Case Reports, with detailed individual case reports of unusual interest or presentation of patient with interesting clinical course or findings or confirming so far speculated processes, may be submitted.
Limit - 2000 words
Abstract - 120 words maximum
References - up to 25
A full-length original articles and case reports should include the following sections: Title Page (including the given name/s and family name/s of each author, the authors' affiliation addresses - indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address, indicate the corresponding author e-mail address), Abstract (number of words specified above), Keywords (4-8), Introduction, Materials and Methods, Results, Discussion, Acknowledgements (if applicable), References, Tables (if applicable), and Figures (if applicable).
Articles describing new or improved relevant methods
Articles describing new or improved relevant methods, containing detailed description of novel techniques, development of established methods or novel application or improved protocols of established methods, can be considered.
Limit - 2500 words
Abstract - 150 words maximum
References - up to 30
Articles describing new or improved relevant methods should include the following sections: Title Page (including the given name/s and family name/s of each author, the authors' affiliation addresses - indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address, indicate the corresponding author e-mail address), Abstract (number of words specified above), Keywords (4-8), Introduction, Discussion, Conclusions, Acknowledgements (if applicable), References, Tables (if applicable), and Figures (if applicable).
References - references follow the American Medical Association (AMA) style i.e, number the references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by superscript Arabic numerals. All authors cited, and only these, must be listed at the end of the paper. List all authors. The titles of journals should be abbreviated according to the List of journals indexed, printed annually in the January issue of Index Medicus.
Persijn GG, Gabb BW, van Leeuwen A, Nagtegaal A, Hoogeboom J, van Rood JJ. Matching for HLA antigens of A, B, and DR loci in renal transplantation by Eurotransplant. Lancet. 1978;1(8077):1278-1281.
Brooker R. Genetics: Analysis and Principles. New York, NY: McGraw-Hill Education; 2015.
Quality and originality of the research and its significance to MEBM readers are the acceptance criteria for all manuscripts. The Editor determines whether the manuscript meets the appropriate quality and relevance requirements and only then initiates the peer review process.
Manuscript that has been published or is being considered for publication elsewhere will not be accepted. Manuscripts that appear to meet the goals of the Journal will be reviewed by two independent reviewers before a decision is made on publication by responsible editor.
Manuscript submission, processing and publishing is free of charge.
PEER REVIEW POLICY
MEBM uses a double-blind review process. All manuscripts are initially evaluated by the editor who then selects and decides which of the articles submitted to MEBM meets the criteria for publishing in MEBM. Each manuscript considered suitable is sent to two independent peer reviewers who are experts in the required field. The final decision regarding whether or not the manuscript is accepted or rejected is made by the editor.
RESEARCH ETHICS POLICY
Conduct and reporting of human research must be in accordance with the Helsinki Declaration as revised in 2013. Additionally, authors should obtain approval to conduct research from an independent local, regional or national review body (e.g., ethics committee, institutional review board).
When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed.
INFORMED CONSENT POLICY
Informed consent from all the individuals participating in research must be obtained. Identifying information, including names, initials, or hospital numbers, must not be published in written descriptions, photographs, or pedigrees.
PUBLICATION ETHICS POLICY
Molecular and Experimental Biology in Medicine follows the guidelines given by the Committee on Publication Ethics (COPE) (available at: https://publicationethics.org/files/Code%20of%20Conduct_2.pdf), whose policies detail what is to be expected of all parties involved in the publishing process: authors, editors, reviewers and publishers. Likewise, the journal adheres to the Recommendations for Conduct, Reporting, Editing and Publication of Scholarly work in Medical Journals issued by the International Committee of medical Journal Editors (ICMJE) (available at: http://www.icmje.org/recommendations/ )
CONFLICT OF INTEREST POLICY
Authors must have no conflicting or competing interests that would preclude them to presenting their research in an unbiased manner, and authors must disclose any and all potential conflicts of interest upon submission of their manuscript for publication. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. All authors must submit a list of references and financial support if so requested by the editorial board. All sources of research funding, including direct and indirect financial support, should be disclosed.
DATA SHARING POLICY
Authors are required to provide a data availability statement to confirm the presence or absence of shared data for all accepted manuscripts. This statement should include information about how the data can be accessed as well as identifier (e.g. DOI for data or accession number) from the repository where the data is shared.
CORRECTIONS & ADDITIONS POLICY
Three categories of amendments to the published articles can be made according to the MEBM publication ethics in cases when the integrity and accuracy of the scholarly record is affected:
Erratum: reputation of the MEBM, reputation of the author(s) or integrity of the scholarly record is affected by an error introduced by the publisher.
Corrigendum: reputation of the MEBM, reputation of the author(s) or integrity of the scholarly record is affected by an error introduced by the author(s).
Retraction: published paper is withdrawn due to invalid results or conclusions; published amendment contains retraction request signed by all authors with description of the error and its effect on the paper's conclusions. In cases of disagreement between authors, Editor makes the final decision about the type of amendment.
MEBM journal does not support advertising in any form.
Prior to publication of the manuscript all authors must sign the Author statement form with Copyright transfer agreement.
The publisher (Croatian Society of Biologist in Health Care) has the right to reproduce and distribute manuscripts without asking permission from the author. All manuscripts are subject to CC-BY licence, which permits users to copy and redistribute the material in any medium or format, as well as to remix, transform and build upon material for any purpose, even commercially, provided that the credit is given to the journal and that the original work is properly cited. Complete legal background of license is available at: https://creativecommons.org/licenses/by/4.0/legalcode
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.